[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate

C44H73N3O15 — CID 59801547

IUPAC[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)C(OCCC#N)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@](C)(OC)C[C@@H](C)C(=O)N[C@H](C)[C@H]2OC(=O)O[C@@]21C
InChIInChI=1S/C44H73N3O15/c1-16-31-44(11)36(61-41(51)62-44)27(6)46-38(49)23(2)21-42(9,52-14)35(60-40-34(57-29(8)48)30(47(12)13)20-24(3)55-40)25(4)33(26(5)39(50)58-31)59-32-22-43(10,53-15)37(28(7)56-32)54-19-17-18-45/h23-28,30-37,40H,16-17,19-22H2,1-15H3,(H,46,49)/t23-,24-,25+,26-,27-,28+,30+,31-,32+,33+,34-,35-,36-,37?,40+,42-,43-,44-/m1/s1
InChIKeyCVQKJPKVANNBJP-USIVQUFGSA-N
MW884.07 g/mol
LogP4.43
Rot. Bonds12

About [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate

[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate (PubChem CID 59801547) has the molecular formula C44H73N3O15 and a molecular weight of 884.07 g/mol. Its IUPAC name is [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate.

Molecular Properties

Compound Name[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
PubChem CID59801547
Molecular FormulaC44H73N3O15
Molecular Weight884.07 g/mol
Exact Mass883.50
IUPAC Name[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)C(OCCC#N)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@](C)(OC)C[C@@H](C)C(=O)N[C@H](C)[C@H]2OC(=O)O[C@@]21C
InChIInChI=1S/C44H73N3O15/c1-16-31-44(11)36(61-41(51)62-44)27(6)46-38(49)23(2)21-42(9,52-14)35(60-40-34(57-29(8)48)30(47(12)13)20-24(3)55-40)25(4)33(26(5)39(50)58-31)59-32-22-43(10,53-15)37(28(7)56-32)54-19-17-18-45/h23-28,30-37,40H,16-17,19-22H2,1-15H3,(H,46,49)/t23-,24-,25+,26-,27-,28+,30+,31-,32+,33+,34-,35-,36-,37?,40+,42-,43-,44-/m1/s1
InChIKeyCVQKJPKVANNBJP-USIVQUFGSA-N
XLogP4.43
TPSA208.87 Ų
H-Bond Donors1
H-Bond Acceptors17
Rotatable Bonds12
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500884.07
LogP ≤ 54.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The IUPAC name of [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate (CID 59801547) is [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate.
What is the SMILES notation for [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The canonical SMILES for [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate is CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)C(OCCC#N)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@](C)(OC)C[C@@H](C)C(=O)N[C@H](C)[C@H]2OC(=O)O[C@@]21C.
What is the InChIKey of [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
The InChIKey is CVQKJPKVANNBJP-USIVQUFGSA-N. The full InChI is InChI=1S/C44H73N3O15/c1-16-31-44(11)36(61-41(51)62-44)27(6)46-38(49)23(2)21-42(9,52-14)35(60-40-34(57-29(8)48)30(47(12)13)20-24(3)55-40)25(4)33(26(5)39(50)58-31)59-32-22-43(10,53-15)37(28(7)56-32)54-19-17-18-45/h23-28,30-37,40H,16-17,19-22H2,1-15H3,(H,46,49)/t23-,24-,25+,26-,27-,28+,30+,31-,32+,33+,34-,35-,36-,37?,40+,42-,43-,44-/m1/s1.
What are the key properties of [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate?
[(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate has a molecular weight of 884.07 g/mol, XLogP of 4.43, 12 rotatable bonds, 1 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3R,4S,6R)-2-[[(1R,2R,5R,6S,7S,8R,9R,11R,14R,15R)-6-[(2R,4R,6S)-5-(2-cyanoethoxy)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,14-hexamethyl-4,12,17-trioxo-3,16,18-trioxa-13-azabicyclo[13.3.0]octadecan-8-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate is sourced from PubChem (CID 59801547), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).